Khiron Pharma ApS: Financial statements 2020
CVR: 37002984
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Khiron Pharma ApS (CVR 37002984) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -6,501 and a net result of DKK -75,172 compared with DKK 64,014 the year before. Equity in the 2020 report amounted to DKK 7,536. The solvency ratio was 16.4%.
- Gross Profit
- DKK -6,501
- Profit/Loss
- DKK -75,172
- Equity
- DKK 7,536
- Total Assets
- DKK 45,895
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -7 t. | -75 t. | 8 t. | 0 |
| 2019 | - | -7 t. | 64 t. | 83 t. | 0 |
| 2018 | - | -8 t. | 10 t. | 19 t. | 0 |
| 2017 | - | - | 22 t. | 8 t. | 0 |
Official annual report
How creditworthy is Khiron Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Khiron Pharma ApS has published its annual report for 2019. Gross profit came to DKK -7,252, and the net result was DKK 64,014.
About Khiron Pharma ApS
Khiron Pharma ApS was a Danish company of the type Anpartsselskab based in Fuglebjerg, founded in 2015. The company has been dissolved on 6 December 2021. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK -6,501 and a net result of DKK -75,172 compared with DKK 64,014 the year before. Equity in the 2020 report amounted to DKK 7,536.